{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:37:46Z","timestamp":1780144666213,"version":"3.54.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":269,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jtauto.2021.100126","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T18:08:44Z","timestamp":1632938924000},"page":"100126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis"],"prefix":"10.1016","volume":"4","author":[{"given":"Nikolaos K.","family":"Gatselis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Azariadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Lyberopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2021.100126_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European association for the study of the, EASL clinical practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib2","first-page":"1","article-title":"Hellenic association for the study of the liver clinical practice Guidelines: autoimmune hepatitis","volume":"32","author":"Dalekos","year":"2019","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.jtauto.2021.100126_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2021.100126_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and Guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2021.100126_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis -- current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2021.100126_bib6","first-page":"1592","article-title":"Autoimmune hepatitis in patients aged 70 years or older: disease characteristics, treatment response and outcome, Liver","volume":"41","author":"Dalekos","year":"2021","journal-title":"Bar Int."},{"key":"10.1016\/j.jtauto.2021.100126_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib8","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/liv.14480","article-title":"Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study","volume":"40","author":"Gr\u00f8nb\u00e6k","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2021.100126_bib9","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.jtauto.2021.100125","article-title":"Impact of genetic and environmental factors on autoimmune hepatitis","volume":"4","author":"Zachou","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100126_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100126_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2021.100126_bib12","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","article-title":"Genetic distinctions between autoimmune hepatitis in Italy and North America","volume":"11","author":"Muratori","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2021.100126_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"van Gerven","year":"2015","journal-title":"Gene Immun."},{"key":"10.1016\/j.jtauto.2021.100126_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","article-title":"J. Autoimmune hepatitis study group-subgroup of the intractable hepato-biliary disease study group in, autoimmune hepatitis in Japan: trends in a nationwide survey","volume":"52","author":"Takahashi","year":"2017","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2021.100126_bib15","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.3748\/wjg.v25.i45.6579","article-title":"Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions","volume":"25","author":"Czaja","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2021.100126_bib16","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis--Update","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2021.100126_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib21","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/eji.201344423","article-title":"PD-1 regulates extrathymic regulatory T-cell differentiation","volume":"44","author":"Chen","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2021.100126_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2021.100126_bib25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","article-title":"Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice","volume":"9","author":"Okazaki","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtauto.2021.100126_bib26","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1073\/pnas.0710951105","article-title":"PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice","volume":"105","author":"Yoshida","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jtauto.2021.100126_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2021.100126_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"De Martin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib29","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Haanen","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jtauto.2021.100126_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jtauto.2021.100126_bib31","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.20280","article-title":"Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope","volume":"50","author":"Prokunina","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100126_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/08916934.2015.1058370","article-title":"PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus","volume":"48","author":"Mahmoudi","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2021.100126_bib33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2021.100126_bib34","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100126_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.20514","article-title":"A PD-1 polymorphism is associated with disease progression in multiple sclerosis","volume":"58","author":"Kroner","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2021.100126_bib36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2021.100126_bib37","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.23592","article-title":"Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection","volume":"51","author":"Li","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2021.100126_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jhep.2011.03.015","article-title":"Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C","volume":"55","author":"Tillmann","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2012.04.036","article-title":"Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C","volume":"57","author":"Stattermayer","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib40","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jhep.2012.01.007","article-title":"IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease","volume":"56","author":"Petta","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.02.001","article-title":"NAFLD and autoimmune hepatitis: do not judge a book by its cover","volume":"75","author":"Dalekos","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jtauto.2021.100126_bib42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jgh3.12046","article-title":"Non-alcoholic fatty liver disease in patients with autoimmune hepatitis","volume":"2","author":"Takahashi","year":"2018","journal-title":"JGH Open"},{"key":"10.1016\/j.jtauto.2021.100126_bib43","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/lt.25615","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Dalekos","year":"2019","journal-title":"Liver Transplant."},{"key":"10.1016\/j.jtauto.2021.100126_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/hepr.13252","article-title":"Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis","volume":"49","author":"Zachou","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jtauto.2021.100126_bib45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2021.100126_bib46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib47","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtauto.2021.100126_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2021.100126_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/08916934.2017.1279610","article-title":"Decreased serum DNase1-activity in patients with autoimmune liver diseases","volume":"50","author":"Gatselis","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2021.100126_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143510","article-title":"Serum cartilage oligomeric matrix protein and golgi protein-73: new diagnostic and predictive tools for liver fibrosis and hepatocellular cancer?","volume":"13","author":"Gatselis","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jtauto.2021.100126_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0953-6205(02)00089-4","article-title":"Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview","volume":"13","author":"Dalekos","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jtauto.2021.100126_bib52","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2021.100126_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(13)60460-2","article-title":"Utility of serum samples for IL28B genotyping: a valuable source of genomic DNA","volume":"58","author":"Gatselis","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2021.100126_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/iji.12456","article-title":"Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus","volume":"47","author":"Fathi","year":"2020","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.jtauto.2021.100126_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00393-014-1415-y","article-title":"Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility","volume":"74","author":"Lee","year":"2015","journal-title":"Z. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1572-0241.2006.00948.x","article-title":"Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases","volume":"102","author":"Mataki","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2021.100126_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jgh.12340","article-title":"Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis","volume":"29","author":"Matsumoto","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib60","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/hepr.12305","article-title":"J. Intractable Hepato-Biliary Disease Study Group of, Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis","volume":"44","author":"Miyake","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jtauto.2021.100126_bib61","first-page":"457","article-title":"The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population","volume":"26","author":"Mostowska","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100126_bib62","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.3390\/ijms16059794","article-title":"Association between PDCD1 gene polymorphisms and risk of systemic lupus erythematosus in three main ethnic groups of the Malaysian population","volume":"16","author":"Chua","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2021.100126_bib63","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/art.20436","article-title":"Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects","volume":"50","author":"Ferreiros-Vidal","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100126_bib64","doi-asserted-by":"crossref","first-page":"36885","DOI":"10.18632\/oncotarget.16378","article-title":"Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtauto.2021.100126_bib65","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gene.2012.09.119","article-title":"Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study","volume":"511","author":"Bayram","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.jtauto.2021.100126_bib66","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.26506","article-title":"Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2021.100126_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037998","article-title":"Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease","volume":"7","author":"Agundez","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2021.100126_bib68","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2021.100126_bib69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2021.100126_bib70","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2021.100126_bib71","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jhep.2012.09.035","article-title":"IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients","volume":"58","author":"Garrett","year":"2013","journal-title":"J. Hepatol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:42:49Z","timestamp":1762904569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909021000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":71,"alternative-id":["S2589909021000460"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100126","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100126"}}